Janux Therapeutics, Inc. (JANX)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-31 | Campbell David Alan | director | G | 123,840 | 0 | $0 |
| 2026-07-08 | Campbell David Alan | director | M | 7,000 | 4.21 | $29,470 |
| 2026-06-11 | RA Capital Nexus Fund II, L.P. | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | Simson Jake | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | Kung Winston | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | Hernday Natasha | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | DOBMEIER ERIC | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | CAPPS VICKIE L | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | Barrett Ronald W | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund II, L.P.; Kolchinsky Peter; Shah Rajeev M. | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | Simson Jake | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | Kung Winston | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | Hernday Natasha | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | DOBMEIER ERIC | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | CAPPS VICKIE L | director | A | 5,500 | 0 | $0 |
| 2026-06-11 | Barrett Ronald W | director | A | 5,500 | 0 | $0 |
| 2026-06-02 | Doyle Janeen Noel | officer | S | 4,059 | 14.03 | $56,948 |
| 2026-06-02 | Doyle Janeen Noel | officer | S | 4,059 | 14.03 | $56,944 |
| 2026-05-11 | Dobek Maria | officer | S | 2,038 | 14.17 | $28,878 |
| 2026-05-11 | Dobek Maria | officer | S | 2,038 | 14.17 | $28,878 |
| 2026-02-02 | Go William | officer | A | 44,000 | 0 | $0 |
| 2026-02-02 | Go William | officer | A | 44,000 | 0 | $0 |
| 2026-01-02 | Meyer Andrew Hollman | officer | S | 1,879 | 13.73 | $25,799 |
| 2026-01-02 | DiRaimondo Thomas | officer | S | 2,505 | 13.73 | $34,394 |
| 2026-01-02 | DiRaimondo Thomas | officer | A | 31,400 | 0 | $0 |
| 2026-01-02 | Campbell David Alan | director | A | 96,600 | 0 | $0 |
| 2026-01-02 | Campbell David Alan | director | S | 8,072 | 13.73 | $110,829 |
| 2026-01-02 | Winter Charles M. | officer | A | 28,600 | 0 | $0 |
| 2026-01-02 | Winter Charles M. | officer | S | 2,401 | 13.73 | $32,966 |
| 2026-01-02 | McIver Zachariah | officer | A | 29,000 | 0 | $0 |
| 2026-01-02 | McIver Zachariah | officer | S | 2,714 | 13.73 | $37,263 |
| 2026-01-02 | Doyle Janeen Noel | officer | A | 36,000 | 0 | $0 |
| 2026-01-02 | Dobek Maria | officer | A | 18,935 | 0 | $0 |
| 2026-01-02 | Dobek Maria | officer | S | 1,462 | 13.73 | $20,073 |
| 2026-01-02 | Meyer Andrew Hollman | officer | S | 1,879 | 13.73 | $25,799 |
| 2026-01-02 | DiRaimondo Thomas | officer | S | 2,505 | 13.73 | $34,394 |
| 2026-01-02 | DiRaimondo Thomas | officer | A | 31,400 | 0 | $0 |
| 2026-01-02 | Campbell David Alan | director | S | 8,072 | 13.73 | $110,829 |
| 2026-01-02 | Campbell David Alan | director | A | 96,600 | 0 | $0 |
| 2026-01-02 | Winter Charles M. | officer | S | 2,401 | 13.73 | $32,966 |
| 2026-01-02 | Winter Charles M. | officer | A | 28,600 | 0 | $0 |
| 2026-01-02 | McIver Zachariah | officer | S | 2,714 | 13.73 | $37,263 |
| 2026-01-02 | McIver Zachariah | officer | A | 29,000 | 0 | $0 |
| 2026-01-02 | Doyle Janeen Noel | officer | A | 36,000 | 0 | $0 |
| 2026-01-02 | Dobek Maria | officer | S | 1,462 | 13.73 | $20,073 |
| 2026-01-02 | Dobek Maria | officer | A | 18,935 | 0 | $0 |
| 2025-12-01 | Meyer Andrew Hollman | officer | S | 633 | 33.52 | $21,218 |
| 2025-12-01 | Meyer Andrew Hollman | officer | S | 2,700 | 32.85 | $88,695 |
| 2025-12-01 | Meyer Andrew Hollman | officer | M | 3,333 | 10.59 | $35,296 |
| 2025-12-01 | Meyer Andrew Hollman | officer | M | 3,333 | 10.59 | $35,296 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-13 SCHEDULE 13G/A
- 2026-08-06 10-Q
- 2026-08-06 8-K
- 2026-07-31 4
- 2026-07-10 4
- 2026-06-23 8-K
- 2026-06-12 4
- 2026-06-12 4
- 2026-06-12 4
- 2026-06-12 4
- 2026-06-12 4
- 2026-06-12 4
- 2026-06-12 4
- 2026-06-12 8-K
- 2026-06-04 4
- 2026-06-02 144
- 2026-05-15 SCHEDULE 13G/A
- 2026-05-13 4
- 2026-05-12 SCHEDULE 13G